Spyre Therapeutics, Inc. | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Enrolling by invitation	Phase 2	2026-10-06		NCT07652294
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Recruiting	Phase 2	2026-10-06		NCT07012395
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)	Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder	Not yet recruiting	Phase 2	2026-08-14		NCT07766005
A Study of SPY072 in Rheumatic Disease	Axial Spondyloarthritis, Collagen Diseases, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatoid arthritis, skin disorder, spondylitis, vertebral column disorder	Active, not recruiting	Phase 2	2026-06-05		NCT07148414
A Study of SPY003-207 in Healthy Volunteers	Healthy	Active, not recruiting	Phase 1	2026-03-20		NCT06873724